Tumor formation in Brca1 conditional mutant mice.

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• BRCA1 is a critical tumor suppressor gene linked to hereditary breast and ovarian cancers.
• Brca1 mutations in mice typically cause embryonic lethality due to proliferation defects, hindering cancer mechanism studies.
• Understanding Brca1's role in tumor suppression requires models that bypass early lethality.

Purpose of the Study:

• To investigate the role of BRCA1 in mammary tumorigenesis by creating a conditional knockout mouse model.
• To explore the mechanisms underlying Brca1-deficient tumor formation and identify associated molecular alterations.

Main Methods:

• Engineered Brca1 gene by flanking exon 11 with loxP sites for conditional deletion.
• Utilized EIIA-Cre (germline) and MMTV-Cre (mammary epithelium) systems to delete the Brca1 exon.
• Analyzed tumor development, histopathology, and molecular profiles in genetically modified mice, including p53 heterozygous backgrounds.

Main Results:

• Germline deletion of Brca1 exon 11 using EIIA-Cre led to p53-dependent embryonic lethality.
• Mammary-specific deletion of Brca1 exon 11 using MMTV-Cre resulted in low-frequency, long-latency mammary tumors.
• Tumorigenesis was accelerated in p53(+/-) mice but remained stochastic, indicating involvement of additional factors.
• Brca1-deficient tumors exhibited diverse histopathology and molecular alterations, including overexpression of ErbB2, c-Myc, p27, Cyclin D1, and downregulation of p16.

Conclusions:

• Conditional deletion of Brca1 in mice provides a model to study its role in mammary tumorigenesis.
• Brca1 deficiency contributes to mammary tumor development, often involving p53 and other oncogenic pathways.
• The diverse molecular landscape of Brca1-deficient tumors highlights complex interactions in cancer progression.